1. Home/
  2. Compounds/
  3. selumetinib:navitoclax (8:1 mol/mol)

selumetinib:navitoclax (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:navitoclax (8:1 mol/mol)
PharmacoGx selumetinib:navitoclax (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:navitoclax (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ETV6 CTRPv2 pan-cancer AAC 0.28 2e-13
mRNA NRROS CTRPv2 pan-cancer AAC 0.34 4e-13
mRNA IRF2BP2 CTRPv2 pan-cancer AAC 0.26 4e-12
mRNA GRAMD4 CTRPv2 pan-cancer AAC 0.26 4e-11
mRNA ZFP36L2 CTRPv2 pan-cancer AAC 0.26 4e-11
mRNA C16orf87 CTRPv2 pan-cancer AAC -0.23 6e-10
mRNA ASB3 CTRPv2 pan-cancer AAC -0.23 9e-10
mRNA LGALS9 CTRPv2 pan-cancer AAC 0.24 1e-09
mRNA PRPS1 CTRPv2 pan-cancer AAC -0.23 1e-09
mRNA TSNARE1 CTRPv2 pan-cancer AAC 0.22 2e-09
Download CSV